title: Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.
authors.affiliation: Pediatric Gastroenterology & Hepatology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain and Cliniques Universitaires Saint Luc, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
authors.forename: Etienne M
authors.initials: EM
authors.lastname: Sokal
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Paganelli
authors.forename: Stefan
authors.initials: S
authors.lastname: Wirth
authors.forename: Piotr
authors.initials: P
authors.lastname: Socha
authors.forename: Pietro
authors.initials: P
authors.lastname: Vajro
authors.forename: Florence
authors.initials: F
authors.lastname: Lacaille
authors.forename: Deirdre
authors.initials: D
authors.lastname: Kelly
authors.forename: Giorgina
authors.initials: G
authors.lastname: Mieli-Vergani
mesh_terms: D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002648:Child; D005260:Female; D017325:Hepatitis B Vaccines / Q000494:pharmacology; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000517:prevention & control / Q000821:virology; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000209:etiology; D008297:Male; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines
keywords: ALT; Acute hepatitis B; Adolescents; Breastfeeding; CHB; Children; Chronic hepatitis B; FDA; Food and Drug Administration; Guidelines; HBIG; HBV; HCC; Hepatitis B virus; IFN; Immunosuppressed; Management; NA; PegINF; Pregnancy; Resistance; SVR; Transplantation; Treatment; ULN; VR; WHO; World Health Organization; alanine aminotransferases; cccDNA; chronic hepatitis B; covalently closed circular DNA; hepatitis B immunoglobulins; hepatitis B virus; hepatocellular carcinoma; interferon; nucleos(t)ide analogues; pegylated interferon; sustained virological response; upper limit of normal; virologic response